More on ROIV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-265.2% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (5/29/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Roivant Sciences (NQ:ROIV)
Delayed: 28.78 -0.94 (3.16%)
Prev. Close $29.72  
Open$29.20 
52 Wk High$ 
52 Wk Low$ 
Day High$29.38 
Day Low$28.31 
P/E N/A  
EPS$ 
Volume5,686,422 

Friends, Peers and Foes (?): IMVT, ABUS, ROIVW, ABBV, AMGN (more...)

Mar 6, 2026 10:05 AM Form SCHEDULE 13G/A Roivant Sciences Ltd. Filed by: FMR LLC
Mar 4, 2026 08:36 AM TD Cowen Reiterates Buy Rating and Top Pick on Roivant Sciences (ROIV)
Mar 4, 2026 06:41 AM Roivant Sciences (ROIV) PT Raised to $34 at H.C. Wainwright
Mar 3, 2026 05:30 PM Wolfe Research Reiterates Outperform Rating on Roivant Sciences (ROIV)
Mar 3, 2026 04:33 PM After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
Mar 3, 2026 04:21 PM Form 8-K Roivant Sciences Ltd. For: Mar 03
Mar 3, 2026 04:16 PM Roivant's Genevant and Arbutus reach $2.25 billion settlement with Moderna
Mar 3, 2026 04:15 PM Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna
Mar 3, 2026 04:15 PM Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
Mar 3, 2026 10:51 AM Jefferies Reiterates Buy Rating on Roivant Sciences (ROIV) amid Brepocitinib NDA acceptance
View All Articles

Entities mentioned with ROIV

View All Entities